Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Liabilities from Discontinued Operations: 2021-2023

Historic Liabilities from Discontinued Operations for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Dec 2023 value amounting to $45,000.

  • Insight Molecular Diagnostics' Liabilities from Discontinued Operations fell 97.76% to $45,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $45,000, marking a year-over-year decrease of 97.76%. This contributed to the annual value of $45,000 for FY2023, which is 97.76% down from last year.
  • Insight Molecular Diagnostics' Liabilities from Discontinued Operations amounted to $45,000 in Q4 2023, which was down 50.00% from $90,000 recorded in Q3 2023.
  • In the past 5 years, Insight Molecular Diagnostics' Liabilities from Discontinued Operations registered a high of $2.0 million during Q4 2022, and its lowest value of $45,000 during Q4 2023.
  • In the last 3 years, Insight Molecular Diagnostics' Liabilities from Discontinued Operations had a median value of $135,000 in 2023 and averaged $760,200.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Liabilities from Discontinued Operations surged by 31.39% in 2022 and then slumped by 97.76% in 2023.
  • Over the past 3 years, Insight Molecular Diagnostics' Liabilities from Discontinued Operations (Quarterly) stood at $1.5 million in 2021, then skyrocketed by 31.39% to $2.0 million in 2022, then crashed by 97.76% to $45,000 in 2023.
  • Its Liabilities from Discontinued Operations was $45,000 in Q4 2023, compared to $90,000 in Q3 2023 and $135,000 in Q2 2023.